Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni
Objective: The aim of this study was to develop a vaccine against schistosomiasis, which is a major challenge due to the complex lifecycle of the causative schistosome parasite. Methods: SmKI-1 is a 16-kDa Kunitz-type protease inhibitor present in the excretory–secretory products and tegument of adu...
Main Authors: | Shiwanthi L. Ranasinghe, Mary Duke, Marina Harvie, Donald P. McManus |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971217302813 |
Similar Items
-
Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice
by: Suellen B. Morais, et al.
Published: (2018-07-01) -
Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis
by: Juan Hernández-Goenaga, et al.
Published: (2019-11-01) -
La schistosomiasis mansoni en Venezuela
by: J. M. Ruiz Rodríguez
Published: (1943-11-01) -
Acute human schistosomiasis mansoni
by: Ana Rabello
Published: (1995-04-01) -
Duplex Hemodinamic evaluation of hepatosplenic mansoni schistosomiasis
by: D. C. Paranaguá-Vezozzo, et al.
Published: (1992-01-01)